Asthma Clinical Trials in Hohhot
7 recruitingHohhot, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
Severe Asthma
AstraZeneca400 enrolled75 locationsNCT07363642
Recruiting
Phase 3
A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
Asthma
AstraZeneca790 enrolled101 locationsNCT06471257
Recruiting
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
Asthma
AstraZeneca355 enrolled21 locationsNCT06419413
Recruiting
Phase 3
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
AstraZeneca440 enrolled131 locationsNCT06307665
Recruiting
Phase 2
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
AstraZeneca540 enrolled208 locationsNCT06932263
Recruiting
Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Asthma
Sanofi1,147 enrolled240 locationsNCT06676319
Recruiting
Phase 2
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma.
Asthma
Sanofi900 enrolled114 locationsNCT06609239